Campbell & CO Investment Adviser LLC Myriad Genetics Inc Transaction History
Campbell & CO Investment Adviser LLC
- $1.24 Billion
- Q4 2024
A detailed history of Campbell & CO Investment Adviser LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Campbell & CO Investment Adviser LLC holds 126,985 shares of MYGN stock, worth $1.9 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
126,985Holding current value
$1.9 Million% of portfolio
0.14%Shares
4 transactions
Others Institutions Holding MYGN
# of Institutions
227Shares Held
92MCall Options Held
297KPut Options Held
20.7K-
Black Rock Inc. New York, NY15.2MShares$227 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.6MShares$159 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA6MShares$89.9 Million0.02% of portfolio
-
State Street Corp Boston, MA5.53MShares$82.8 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.35MShares$65.1 Million0.03% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $1.21B
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...